CEO, Armon Bättig, and Composite Recycling’s newly appointed CEO, Smaranda Jaun are not unfamiliar faces. Both had already played key roles in steering their startups toward sustainable growth, and ...

Geistlich Pharma AG has acquired a minority stake in TRI Dental Implants Int. AG fast-growing global provider for inspiring digital implant solutions. The investment underscores a shared vision in ...

The SEF.Growth High Potential Label acts as a seal of quality for companies that have strong growth strategies and high potential for significant market impact. The label enhances startups' ...

Organised by the Luxury Venture Group (LVG), the ‘Luxury Innovation Awards’ is a global c ompetition for startups and emerging brands recognizing their innovation, creativity, ...

Enerdrape is setting the pace in the US. The EPFL spin-off is working currently on the Millennium Parking Garages in Chicago, the largest downtown public underground parking system in North America, ...

EPFL spin-off Lemna Bio has raised CHF 150,000 from Venture Kick to develop its physics-driven AI platform, which makes ...

The new presence in Luxembourg is an additional step to expand our international footprint. The CYSEC Lab focuses on research and development of cybersecurity solutions for critical infrastructures, ...

CustomSurg’s innovative digital platform, OrthoPlanner (picture above), has been cleared from the U.S. Food and Drug Administration (FDA) as a medical device product. The software tool empowers ...

Hanwha Phasor was launched in June 2020 by South Korean Hanwha Group by acquiring assets of Phasor Solutions. The company is known for its enterprise-grade flat-panel antennas for satellite ...

Intrapreneurship teams Five teams from corporate organizations have also been selected to further advance their solutions. KUORI (HSG START Accelerator), SecondWave (CSEM), SmartHear (CSEM), HELIOW ...

The second tranche of the Series C round brings total funds raised to more than CHF 125 million. The proceeds will be used to progress with the Phase 3 trial of the lead product denovoSkin and to ...

In a second program, supported by a CHF 1.5 million Innosuisse grant, cellvie is developing a mitochondria-enabled gene delivery platform that leverages the organelle’s unique biodistribution and ...